Jury hits AstraZeneca with $215 million fine in price-inflation case PhRMA spent more than $22 million in lobbying efforts in 2007 FDA approves Xyntha for Hemophilia A Prasugrel given priority review by FDA Teva introduces generic equivalent of Novartis’ Trileptal The California Pharmacy Hall of Fame announces its three new recipients FDA approves Avastin to treat breast cancer FDA approves Humira for juvenile arthritis Study indicates that taking multiple NSAIDs may lead to poorer health EMEA recommends pre-pandemic bird flu vaccine First Previous 2562 2563 2564 2565 2566 Next Last